Listed

Immunic, Inc.

IMUXNasdaqCIK 1280776HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$35.3m, Q2 FY2026
Net income−$34.1m, Q2 FY2026
Immunic, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m19.8Research and development, Q3 FY2023, three months to 2023-09-30$19.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001280776-24-000018.Report this figure19.3Research and development, Q4 FY2023, three months to 2023-12-31$19.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001280776-25-000005. Derived: 12-month figure less the 9-month figure.Report this figure18.7Research and development, Q1 FY2024, three months to 2024-03-31$18.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001280776-25-000008.Report this figure18.3Research and development, Q2 FY2024, three months to 2024-06-30$18.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001280776-25-000012.Report this figure21.4Research and development, Q3 FY2024, three months to 2024-09-30$21.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure21.6Research and development, Q4 FY2024, three months to 2024-12-31$21.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001280776-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure21.5Research and development, Q1 FY2025, three months to 2025-03-31$21.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure21.4Research and development, Q2 FY2025, three months to 2025-06-30$21.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure20.0Research and development, Q3 FY2025, three months to 2025-09-30$20.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure19.1Research and development, Q4 FY2025, three months to 2025-12-31$19.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001280776-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure25.6Research and development, Q1 FY2026, three months to 2026-03-31$25.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure25.9Research and development, Q2 FY2026, three months to 2026-06-30$25.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure
Operating income$m(23.6)Operating income, Q3 FY2023, three months to 2023-09-30−$23.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001280776-24-000018.Report this figure(23.4)Operating income, Q4 FY2023, three months to 2023-12-31−$23.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001280776-25-000005. Derived: 12-month figure less the 9-month figure.Report this figure(23.9)Operating income, Q1 FY2024, three months to 2024-03-31−$23.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001280776-25-000008.Report this figure(22.8)Operating income, Q2 FY2024, three months to 2024-06-30−$22.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001280776-25-000012.Report this figure(25.7)Operating income, Q3 FY2024, three months to 2024-09-30−$25.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure(25.6)Operating income, Q4 FY2024, three months to 2024-12-31−$25.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001280776-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure(26.8)Operating income, Q1 FY2025, three months to 2025-03-31−$26.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure(27.1)Operating income, Q2 FY2025, three months to 2025-06-30−$27.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure(26.0)Operating income, Q3 FY2025, three months to 2025-09-30−$26.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure(23.3)Operating income, Q4 FY2025, three months to 2025-12-31−$23.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001280776-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure(33.2)Operating income, Q1 FY2026, three months to 2026-03-31−$33.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure(35.3)Operating income, Q2 FY2026, three months to 2026-06-30−$35.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure
Net income$m(22.8)Net income, Q3 FY2023, three months to 2023-09-30−$22.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001280776-24-000018.Report this figure(21.6)Net income, Q4 FY2023, three months to 2023-12-31−$21.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001280776-25-000005. Derived: 12-month figure less the 9-month figure.Report this figure(29.6)Net income, Q1 FY2024, three months to 2024-03-31−$29.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure(21.4)Net income, Q2 FY2024, three months to 2024-06-30−$21.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure(24.4)Net income, Q3 FY2024, three months to 2024-09-30−$24.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure(25.2)Net income, Q4 FY2024, three months to 2024-12-31−$25.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001280776-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure(25.5)Net income, Q1 FY2025, three months to 2025-03-31−$25.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure(26.8)Net income, Q2 FY2025, three months to 2025-06-30−$26.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure(25.6)Net income, Q3 FY2025, three months to 2025-09-30−$25.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure(19.3)Net income, Q4 FY2025, three months to 2025-12-31−$19.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001280776-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure(32.6)Net income, Q1 FY2026, three months to 2026-03-31−$32.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure(34.1)Net income, Q2 FY2026, three months to 2026-06-30−$34.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure
Diluted EPS$ per share(0.51)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001280776-24-000018.Report this figurenot reported(0.30)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001280776-25-000008.Report this figure(0.21)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001280776-25-000012.Report this figure(0.24)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figurenot reported(2.51)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$2.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure(2.03)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$2.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure(0.13)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figurenot reported(1.08)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure(0.80)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure
Basic EPS$ per share(0.51)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001280776-24-000018.Report this figurenot reported(0.30)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001280776-25-000008.Report this figure(0.21)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001280776-25-000012.Report this figure(0.24)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figurenot reported(2.51)Basic EPS, Q1 FY2025, three months to 2025-03-31−$2.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure(2.03)Basic EPS, Q2 FY2025, three months to 2025-06-30−$2.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure(0.13)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figurenot reported(1.08)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure(0.80)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure

Balance sheet

Cash and equivalents$155.1m, Q2 FY2026
Shareholders' equity$127.6m, Q2 FY2026
Immunic, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m59.7Cash and equivalents, Q3 FY2023, at 2023-09-30$59.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001280776-23-000018.Report this figure46.7Cash and equivalents, FY2023, at 2023-12-31$46.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001280776-25-000005.Report this figure97.3Cash and equivalents, Q1 FY2024, at 2024-03-31$97.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0001280776-24-000009.Report this figure79.7Cash and equivalents, Q2 FY2024, at 2024-06-30$79.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001280776-24-000014.Report this figure59.1Cash and equivalents, Q3 FY2024, at 2024-09-30$59.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001280776-24-000018.Report this figure35.7Cash and equivalents, FY2024, at 2024-12-31$35.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001280776-26-000005.Report this figure14.3Cash and equivalents, Q1 FY2025, at 2025-03-31$14.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001280776-25-000008.Report this figure55.3Cash and equivalents, Q2 FY2025, at 2025-06-30$55.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001280776-25-000012.Report this figure35.1Cash and equivalents, Q3 FY2025, at 2025-09-30$35.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure15.5Cash and equivalents, FY2025, at 2025-12-31$15.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure187Cash and equivalents, Q1 FY2026, at 2026-03-31$186.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure155Cash and equivalents, Q2 FY2026, at 2026-06-30$155.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure
Current assets$m65.2Current assets, Q3 FY2023, at 2023-09-30$65.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001280776-23-000018.Report this figure52.5Current assets, FY2023, at 2023-12-31$52.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001280776-25-000005.Report this figure103Current assets, Q1 FY2024, at 2024-03-31$102.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001280776-24-000009.Report this figure85.0Current assets, Q2 FY2024, at 2024-06-30$85.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001280776-24-000014.Report this figure63.3Current assets, Q3 FY2024, at 2024-09-30$63.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001280776-24-000018.Report this figure39.3Current assets, FY2024, at 2024-12-31$39.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001280776-26-000005.Report this figure19.0Current assets, Q1 FY2025, at 2025-03-31$19.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001280776-25-000008.Report this figure59.8Current assets, Q2 FY2025, at 2025-06-30$59.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001280776-25-000012.Report this figure39.3Current assets, Q3 FY2025, at 2025-09-30$39.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure22.9Current assets, FY2025, at 2025-12-31$22.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure189Current assets, Q1 FY2026, at 2026-03-31$188.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure158Current assets, Q2 FY2026, at 2026-06-30$157.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure
Total assets$m67.0Total assets, Q3 FY2023, at 2023-09-30$67.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001280776-23-000018.Report this figure54.3Total assets, FY2023, at 2023-12-31$54.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001280776-25-000005.Report this figure104Total assets, Q1 FY2024, at 2024-03-31$104.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001280776-24-000009.Report this figure86.5Total assets, Q2 FY2024, at 2024-06-30$86.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001280776-24-000014.Report this figure64.8Total assets, Q3 FY2024, at 2024-09-30$64.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001280776-24-000018.Report this figure40.9Total assets, FY2024, at 2024-12-31$40.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001280776-26-000005.Report this figure20.5Total assets, Q1 FY2025, at 2025-03-31$20.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001280776-25-000008.Report this figure61.4Total assets, Q2 FY2025, at 2025-06-30$61.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001280776-25-000012.Report this figure40.7Total assets, Q3 FY2025, at 2025-09-30$40.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure24.1Total assets, FY2025, at 2025-12-31$24.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure190Total assets, Q1 FY2026, at 2026-03-31$189.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure159Total assets, Q2 FY2026, at 2026-06-30$159.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure
Current liabilities$m17.8Current liabilities, Q3 FY2023, at 2023-09-30$17.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001280776-23-000018.Report this figure24.7Current liabilities, FY2023, at 2023-12-31$24.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001280776-25-000005.Report this figure20.1Current liabilities, Q1 FY2024, at 2024-03-31$20.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001280776-24-000009.Report this figure22.7Current liabilities, Q2 FY2024, at 2024-06-30$22.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001280776-24-000014.Report this figure23.4Current liabilities, Q3 FY2024, at 2024-09-30$23.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001280776-24-000018.Report this figure22.2Current liabilities, FY2024, at 2024-12-31$22.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001280776-26-000005.Report this figure25.6Current liabilities, Q1 FY2025, at 2025-03-31$25.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001280776-25-000008.Report this figure27.3Current liabilities, Q2 FY2025, at 2025-06-30$27.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001280776-25-000012.Report this figure30.1Current liabilities, Q3 FY2025, at 2025-09-30$30.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure30.6Current liabilities, FY2025, at 2025-12-31$30.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure38.4Current liabilities, Q1 FY2026, at 2026-03-31$38.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure31.3Current liabilities, Q2 FY2026, at 2026-06-30$31.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure
Total liabilities$m18.6Total liabilities, Q3 FY2023, at 2023-09-30$18.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001280776-23-000018.Report this figure25.4Total liabilities, FY2023, at 2023-12-31$25.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001280776-25-000005.Report this figure20.6Total liabilities, Q1 FY2024, at 2024-03-31$20.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0001280776-24-000009.Report this figure22.9Total liabilities, Q2 FY2024, at 2024-06-30$22.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001280776-24-000014.Report this figure23.5Total liabilities, Q3 FY2024, at 2024-09-30$23.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001280776-24-000018.Report this figure22.4Total liabilities, FY2024, at 2024-12-31$22.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001280776-26-000005.Report this figure25.8Total liabilities, Q1 FY2025, at 2025-03-31$25.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001280776-25-000008.Report this figure27.5Total liabilities, Q2 FY2025, at 2025-06-30$27.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001280776-25-000012.Report this figure30.2Total liabilities, Q3 FY2025, at 2025-09-30$30.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure30.7Total liabilities, FY2025, at 2025-12-31$30.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure38.5Total liabilities, Q1 FY2026, at 2026-03-31$38.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure31.6Total liabilities, Q2 FY2026, at 2026-06-30$31.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure
Shareholders' equity$m48.4Shareholders' equity, Q3 FY2023, at 2023-09-30$48.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001280776-24-000018.Report this figure28.9Shareholders' equity, FY2023, at 2023-12-31$28.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001280776-26-000005.Report this figure83.6Shareholders' equity, Q1 FY2024, at 2024-03-31$83.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure63.6Shareholders' equity, Q2 FY2024, at 2024-06-30$63.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure41.2Shareholders' equity, Q3 FY2024, at 2024-09-30$41.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure18.4Shareholders' equity, FY2024, at 2024-12-31$18.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure(5.3)Shareholders' equity, Q1 FY2025, at 2025-03-31−$5.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure33.9Shareholders' equity, Q2 FY2025, at 2025-06-30$33.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure10.5Shareholders' equity, Q3 FY2025, at 2025-09-30$10.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure(6.7)Shareholders' equity, FY2025, at 2025-12-31−$6.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure151Shareholders' equity, Q1 FY2026, at 2026-03-31$151.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure128Shareholders' equity, Q2 FY2026, at 2026-06-30$127.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure

Cash flow

Operating cash flow−$31.0m, Q2 FY2026
Capital expenditure$249.0k, Q2 FY2026
Immunic, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(17.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$17.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001280776-24-000018. Derived: 9-month figure less the 6-month figure.Report this figure(14.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$14.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001280776-25-000005. Derived: 12-month figure less the 9-month figure.Report this figure(24.0)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$24.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001280776-25-000008.Report this figure(17.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$17.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001280776-25-000012. Derived: 6-month figure less the 3-month figure.Report this figure(20.8)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$20.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001280776-25-000017. Derived: 9-month figure less the 6-month figure.Report this figure(23.0)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$23.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001280776-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure(21.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$21.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure(24.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$24.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001280776-26-000018. Derived: 6-month figure less the 3-month figure.Report this figure(20.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$20.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001280776-25-000017. Derived: 9-month figure less the 6-month figure.Report this figure(19.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$19.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001280776-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure(17.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$17.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure(31.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$31.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001280776-26-000018. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$44.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001280776-24-000018. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$165.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0001280776-25-000005. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$31.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0001280776-25-000008.Report this figure0.2Capital expenditure, Q2 FY2024, three months to 2024-06-30$180.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001280776-25-000012. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$50.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001280776-25-000017. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001280776-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$47.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$36.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001280776-26-000018. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$67.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001280776-25-000017. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$11.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001280776-26-000005. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure0.2Capital expenditure, Q2 FY2026, three months to 2026-06-30$249.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001280776-26-000018. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)42.51m, Q2 FY2026
Immunic, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares30.6Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3030,564,995 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001280776-23-000018.Report this figure43.7Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3143,664,783 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001280776-24-000009.Report this figure44.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3044,432,955 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001280776-24-000014.Report this figure44.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3044,574,377 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001280776-24-000018.Report this figure97.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3197,299,955 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001280776-25-000008.Report this figure101Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30101,272,580 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001280776-25-000012.Report this figure101Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30101,272,580 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure10.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3110,134,443 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure13.2Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3013,217,520 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure194Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30193,897,764 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001280776-25-000017.Report this figure30.1Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3130,136,324 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001280776-26-000010.Report this figure42.5Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3042,513,839 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure

Shares outstanding: 13.64mShares outstanding, period not labelled, at 2026-07-3113,644,467 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001280776-26-000018.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. Listed shows no prices and gives no investment advice.